Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DUEL: Zonisamide add-on versus increased levodopa for motor symptoms in DLB parkinsonism
jRCTs051200054Completed
- Sponsor
- Sumitomo Pharma
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of zonisamide in dementia with Lewy bodies (DLB) and parkinsonism (2 arms), sponsored by Sumitomo Pharma. Primary endpoint: Change in MDS-UPDRS Part III total score at Week 24. Started Apr 2021; status: completed.
02
Drugs
zonisamide
03
Conditions
dementia with Lewy bodies (DLB)parkinsonism
Beyond the preview
Go deeper on jRCTs051200054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051200054.